The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly-Reference-Cited by-同舟云学术

The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly

Published:2007-11-07 Issue:1 Volume:11 Page:13-20
ISSN:1386-341X
Container-title:Pituitary
language:en
Short-container-title:Pituitary

Author:

De Marinis Laura,Bianchi Antonio,Mazziotti Gherardo,Mettimano Marco,Milardi Domenico,Fusco Alessandra,Cimino Vincenzo,Maira Giulio,Pontecorvi Alfredo,Giustina Andrea

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11102-007-0062-6.pdf

Reference50 articles.

1. Sacca L, Cittadini A, Fazio S (1994) Growth hormone and the heart. Endocr Rev 15:555–573

2. Giustina A, Casanueva FF, Cavagnini F et al (2003) Diagnosis and treatment of acromegaly complications. J Endocrinol Invest 26:1242–1247

3. Colao A, Ferone D, Marzullo P et al (2004) Systemic complications of acromegaly epidemiology, pathogenesis, and management. Endocr Rev 25:102–152

4. Melmed S (1990) Acromegaly. N Engl J Med 322:966–977

5. Bihan H, Espinosa C, Valdes-Socin H et al (2004) Long-term outcome of patients with acromegaly and congestive heart failure. J Clin Endocrinol Metab 89:5308–5313

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines on diagnostics and treatment of acromegaly (draft);Obesity and metabolism;2024-06-26

2. Pituitary: hic manebimus optime;Pituitary;2024-01-03

3. Acromegaly and Bone: An Update;Endocrinology and Metabolism;2023-12-31

4. Efficacy of long-term octreotide therapy of acromegaly as the first-line medical treatment;Obesity and metabolism;2023-05-23

5. Filling the gap between the heart and the body in acromegaly: a case-control study;Endocrine;2022-10-30